¿ë¾î ] ¿¬±¸¹æ¹ý ] ÇöȲ ] ¹ß»ý¿øÀΠ] ºÐ¸¸ ] ôÃß¼ö¼ú ] º´¿ø°¨¿° ] Áø·á°ú¸ñº° ºÐ·ù ] ÀÇ·á ÇàÀ§º° ºÐ·ù ] Áúȯº° ºÐ·ù ] °ú½Ç À¯Çüº° ºÐ·ù ] ´ëÃ¥ ] ÀÇÇÐÀû ÀÇ»ç°áÁ¤·Ð ] ¹æ¾îÁø·á ] ÆÇ·Ê ] ¼Ò¼Û¿ÜÀû ÀÇ·áºÐÀïÀÇ ÇØ°á ] ÀÇ·áºÐÀïÁ¶Á¤¹ý ] ÀÇ»çÀÇ ¹ýÀû Àǹ« ] ȯÀÚÃøÀÇ ½ÃÀ§ ] ÀÇ·á¹ý·ü ] ¹ý·ü ] ±âÃÊÀÇÇР] ÀÌ»ó¼Ò°ß ] ÀÓ»óÀÇÇР] Áõ·Ê ] ´ºÁú·£µå ] ¹Ì±¹ ] µ¶ÀÏ ] ¿µ±¹ ] ¿À½ºÆ®·¹Àϸ®¾Æ ] ÀÌÅ»¸®¾Æ ] ÀϺ» ] Áß±¹ ] ÇÁ¶û½º ] ij³ª´Ù ] [ ±âŸ ±¹°¡ ] ¹®Çå ] ÀÇ·á¼Ò¼Û ] °Ë»ö ] Medical malpractice ] Kunstfehler in Deutschland ]


¡¡

[ÇöÀçÀ§Ä¡]: Ȩ> ¿Ü±¹

¿Ü±¹ÀÇ ÀÇ·á»ç°í

Brazil ] Denmark ] India ] Mexico ] Taiwan ] Turkey ] Netherland ] Russia ]

¡¡

¡¡

¡¡

  • ÇöȲ
    ±¹°¡ ¿¬±¸³í¹® Ç¥º» Áø·á±â·Ï¼ö ÀÇ·á¼Õ»ó ¹ß»ý ÀÔ¿ø¼ö ÀÇ·á¼Õ»ó ¹ß»ý¼ö °ú½Ç·Î ÀÎÇÑ ÀÇ·á¼Õ»ó¼ö(%) ¿¹¹æ°¡´É¼º ÀÇ·á¼Õ»óÀ¸·Î ÀÎÇÑ ¿¬Àå ÀÔ¿øÀϼö ÃÑ ÀÔ¿ø¼ö¿¡ ´ëÇÑ ÀÇ·á¼Õ»ó ¹ß»ý ÀÔ¿ø¼öÀÇ ºñÀ²  ÀÇ·á¼Õ»óÀÇ °á°ú
    ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ Çѽà ÀåÇØ ¿µ±¸ ÀåÇØ »ç¸Á(°ú½Ç·Î ÀÎÇÑ ÀÇ·á¼Õ»ó¼ö)
    Çѱ¹ ÀÀ±ÞÁø·á±Ç ºÐ¼® ¹× ÀÀ±ÞÀÇ·á±â°ü Æò°¡:ÀÀ±ÞÁø·á±Ç ºÐ¼®. Çѱ¹»ê¾÷º¸°ÇÁøÈï¿ø 202 ¡¡ ¡¡ ¡¡ ÀÀ±Þ »óȲ¿¡¼­ ÀûÀýÈ÷ ´ëóÇßÀ» °æ¿ì »ç¸ÁÀÚÀÇ 26.2%´Â »ì °¡´É¼ºÀÌ 25-75%¿¡ À̸£°í, 13.4%´Â 75% ÀÌ»ó µÆ´Ù ¡¡ ¡¡ ¡¡ ¡¡ ¡¡
    ÀϺ» ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡
    ¹Ì±¹ HMPS 39.121 3.7 % 1,278 306(27.6) ¡¡ ¡¡ ¡¡ 70.5 %(6°³¿ù ÀÌÇÏ) 2.6 % 13.6 %
    UTCOS 15,000 2.9+/-0.2% ¡¡ In Utah, 32.6+/-4%

    In Colorado, 27.4+/-2.4%.

    ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ Death occurred in 6.6+/-1.2% of adverse events and 8.8+/-2.5% of negligent adverse events.
    ¿µ±¹ Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review [published erratum in BMJ 2001;322: 1395]. BMJ 2001;322(7285):517-9.[Free Full Text] ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡
    ¿À½ºÆ®·¹Àϸ®¾Æ ¡¡ 14,179 16.6% ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡
    ´ºÁú·£µå ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡ ¡¡
    µ§¸¶Å© [Incidence of adverse events in hospitals. A retrospective study of medical records] 1.097 114 176 ¡¡ ÀÇ·á¼Õ»ó ¹ß»ý¼öÀÇ 40.4% 7 ÀÏ 9.0% ¡¡ ¡¡ 30 ÀÔ¿ø¼ö¿¡¼­ »ç¸Á ȤÀº ¿µ±¸ ÀåÇØ

  • Taking the Pulse of Health Care Systems: Experiences of Patients with Health Problems in Six Countries. http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w5.509v3

    • ¹Ì º¸°Ç´ÜüÀÎ Ä¿¸ÕÀ£½º ÆÝµå(Commonwealth Fund)´Â ¹Ì±¹, ¿µ±¹, µ¶ÀÏ, È£ÁÖ, ´ºÁú·£µå, ij³ª´Ù µî 6°³±¹ ȯÀÚ 2300¿©¸íÀ» ´ë»óÀ¸·Î Áö³­ 2³â°£ À߸øµÈ Åõ¾à, ºÎÀûÀýÇÑ Ä¡·á, °Ë»ç °á°úÀÇ Áö¿¬ ¹× ½Ç¼ö µîÀÇ ÀÇ·á»ç°í¸¦ Á¶»çÇÑ °á°ú  ¹Ì±¹(34%), ij³ª´Ù´Â 30%, È£ÁÖ 27%, ´ºÁú·£µå 25%, µ¶ÀÏ 23%, ¿µ±¹ 22%·Î Á¶»çµÇ¾ú´Ù.
    • ÀÇ»çÀÇ Áø·á½Ç¿¡¼­ Á¦´ë·Î Á¶Á÷µÇÁö ¾ÊÀº ¾û¼ºÇÑ Ä¡·á¸¦ ¹Þ¾Ò´Ù°í È£¼ÒÇÑ È¯ÀÚÀÇ ºñÀ²Àº ¹Ì±¹(33%), µ¶ÀÏ(26%), ij³ª´Ù(24%). ´ºÁú·£µå(21%)¿Í ¿µ±¹, È£ÁÖ(°¢°¢ 19%)´Â ¼±Áø±¹ ±×·ì¿¡¼­ ȯÀÚ ºÒ¸¸µµ°¡ »ó´ëÀûÀ¸·Î ³·¾Ò´Ù.
    • ij³ª´Ù¿Í ¹Ì±¹ ȯÀÚµéÀº Ä¡·á°¡ ÇÊ¿äÇÑ ½ÃÁ¡¿¡ ÀÇ»çÀÇ Áø·á¸¦ Á¦´ë·Î ¹ÞÁö ¸øÇÏ´Â °ÍÀ» Å« ¾î·Á¿ò Áß Çϳª·Î ÁöÀûÇØ ¾ç±¹ÀÇ ÀÇ»çºÎÁ· Çö½ÇÀ» ¿ìȸÀûÀ¸·Î ÁöÀûÇß´Ù.
    • ij³ª´Ù´Â 5¸íÁß 1¸í, ¹Ì±¹Àº 4¸íÁß 1¸íÀÌ Á¤±âÀûÀ¸·Î ÀÇ»çÁø·á¸¦ ¹Þ´Â´Ù¸é ÀÀ±Þ½ÇÀ» ã´Â Ƚ¼ö°¡ ÁÙ¾îµé °ÍÀ̶ó°í ´äÇß´Ù.
    • Á¤ºÎ°¡ ÀÇ·áºñ¸¦ º¸Á¶ÇÏ´Â ±¹°¡¿Í ±×·¸Áö ¾ÊÀº ±¹°¡¿ÍÀÇ Â÷À̵µ µÎµå·¯Á³´Ù. °³ÀÎÀÌ ÀÇ·áºñ¸¦ ºÎ´ãÇÏ´Â ¹Ì±¹Àº ºñ½Ñ ÀÇ·áºñ ¶§¹®¿¡ ¾àÀ» º¹¿ëÇÒ ¼ö ¾ø¾ú°Å³ª ÀÇ»çÀÇ Áø·á¸¦ ¹ÞÁö ¸øÇߴٴ ȯÀÚ°¡ Àý¹ÝÀ» ³Ñ¾ú´Ù. ±×·¯³ª Á¤ºÎ°¡ ÀÇ·áºñ¸¦ º¸Á¶ÇÏ´Â ¿µ±¹Àº ÀÌ·± ȯÀÚ°¡ 13%¿¡ ºÒ°úÇØ ¹Ì±¹°ú Çö°ÝÇÑ Â÷À̸¦ º¸¿´´Ù.
    • Ä¿¸ÕÀ£½º ÆÝµåÀÇ Äɽà ½ºÄÚ¿£ ºÎȸÀåÀº ¡°¹Ì±¹¿¡¼­´Â ÀϹÝÀûÀ¸·Î º´¿ø¿¡¼­ °« Åð¿øÇÑ È¯ÀÚ³ª ¿©·¯ Àǻ縦 µ¿½Ã¿¡ ¸¸³ª¾ß Çϴ ȯÀÚÀÇ °æ¿ì ºñ½Ñ ÀÇ·áºñ ºÎ´ãÀ» È£¼ÒÇÏ´Â °æ¿ì°¡ ¸¹¾Ò´Ù¡±°í ¹àÇû´Ù.
    • ÀÇ·á»ç°í ºñÀ²ÀÌ ³ôÀº ij³ª´Ù¿Í ¹Ì±¹Àº À̸¦ µÑ·¯½Ñ ¹ýÁ¤ ¼Ò¼Û ºñÀ²µµ ³ô´Ù. Åä·ÐÅäÀÇ ÀÇ·áÀü¹® º¯È£»ç Á¸ ¸ð¸®½º´Â ¡°4-5³âÀü¿¡ ºñÇØ ij-¹Ì ¾ç±¹ÀÇ ÀÇ·á¼Ò¼ÛÀÌ Å©°Ô ´Ã¾ú´Ù¡±°í ÀüÁ¦ÇÑ ÈÄ ¡°±×·¯³ª ¼Ò¼Û ¼öÄ¡°¡ ¹Ýµå½Ã ÀÇ·áÀÇ Áú°ú ÀÏÄ¡ÇÑ´Ù°í´Â »ý°¢ÇÏÁö ¾Ê´Â´Ù¡±°í ¸»Çß´Ù. ij³ª´ÙȯÀÚ¾ÈÀüÇùȸ(CPSI)ÀÇ ÇÊ Çì½¼ ȸÀåÀº ¡°ÀÇ·á½Ç¼ö¸¦ ¹ýÁ¤À¸·Î °¡Á®°¡´Â ´Ü ÇϳªÀÇ ¸ñÀûÀº ±¹³» ÀÇ·á½Ã½ºÅÛÀ» ¼¼°è¿¡¼­ °¡Àå ¾ÈÀüÇÑ ¼öÁØÀ¸·Î °³¼±ÇÏ´Â °Í¡±À̶ó¸ç ¡°Ä³³ª´Ù°¡ ¾ÈÀüµµ¿¡¼­ ¼¼°è 13À§ ¶Ç´Â 7À§¸¦ Â÷ÁöÇÏ´Â °ÍÀº Àǹ̰¡ ¾ø´Ù. ¼¼°è Á¦ÀÏÀÇ ¾ÈÀüÀ̾î¾ß ÇÑ´Ù¡±°í °­Á¶Çß´Ù.
    • Ä¿¸ÕÀ£½ºÆÝµå´Â ÁýÁßÀûÀÎ Ä¡·á¸¦ ¿äÇÏ´Â ½É°¢ÇÑ Áúº´À» °ÞÀº ȯÀÚ³ª ÀӽŠÀÌ¿Ü Áúº´À¸·Î º´¿ø¿¡ ÀÔ¿øÇÑ È¯ÀÚ¸¦ ´ë»óÀ¸·Î ij³ª´Ù, È£ÁÖ, ´ºÁú·£µå¿¡¼­ 700~750¸í, ¿µ±¹, µ¶ÀÏ, ¹Ì±¹¿¡¼­ 1500¸íÀ» ¼±Á¤ÇØ 3¿ùºÎÅÍ 6¿ù »çÀÌ ÀüÈ­¼³¹®À» ½Ç½ÃÇØ À̹ø º¸°í¼­¸¦ ÀÛ¼ºÇß´Ù.
    • http://medical.ymca.or.kr/
    • Any error: medical mistake, medication error, or test error in past two years

  • ±âŸ °ü·Ã»çÀÌÆ® ¹× ¹®Çå

    • Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalised patients. N EnglJ Med 1991;324:370-6
    • Wilson RM, Runciman WB, Gibber RW, Harrison BT, Newby L, Hamilton JD. The quality in Australian health care study. Med J Aust 1995;163:458-71
    • Bates DW, Cullen D, Laird N, et a]. Incidence of adverse drug events: implications for prevention. JAMA 1995;274:29-34
    • Andrews LB, Stocking C, Krizek T, et al. An alternative strategy for studying adverse events in primary care. Lancet 1997;349:309-13
    • http://www.ectil.org/ - EUROPEAN CENTRE OF TORT AND INSURANCE LAW

      • Project

        • Medical liability

          • Many providers of health care services and their insurers are particularly worried about growing medical malpractice. Through an increasing case law, which seems to expand the liability of providers of medical services, the price of insurance coverage for medical malpractice has been rising dramatically in many European countries. This tendency seems to be most apparent in Germany where the evolution in case law towards increased medical malpractice liability does not seem to have come to an end yet. Serious questions arise as a consequence of the medical malpractice explosion in Germany and other countries. One problem is that case law seems to require ever higher standards of care, whereby it is uncertain whether in the public system of provision of medical services (with limited budgets) these very high standards of care can generally be complied with. The evolution towards an expanding medical malpractice liability might give rise to a situation whereby it is unclear whether the very high standard of care required by the case law can be paid for through the health care system. Hence, one can not avoid the fact that there are potentially serious economic consequences in an increasingly rigorous medical malpractice regime. The question arises whether politicians responsible for the financing of the health care system, are aware of these economic consequences. Obviously, in some cases the health care providers have not even followed the minimum level of care that may be required from an average doctor. This may be due to many causes. A lack of adequate organisation in hospitals which are short of financial resources and a high amount of stress for physicians may be among them and the impact of these factors is often apparent in the case law.

          • These and other questions merit further research. This project aims at examining the situation with respect to medical malpractice in a number of European legal systems. The goal of the research project undertaken is particularly to examine whether some general tendencies can be found with respect to evolutions in medical malpractice law and their economic effects.

        • No-fault compensation in the health-care sector

      • Publications

        • Vol. 1: M. Faure/H. Koziol (eds.), Cases on Medical Malpractice in a Comparative Perspective (2001), ISBN 3-211-83595-4

        • Vol. 2: W.V.H. Rogers (ed.), Damages for Non-Pecuniary Loss in a Comparative Perspective (2001), ISBN 3-211-83602-0

        • Vol. 3: U. Magnus (ed.), The Impact of Social Security Law on Tort Law (2003), ISBN 3-211-83795-7

        • Vol. 4: B.A. Koch/H. Koziol (eds.), Compensation for Personal Injury in a Comparative Perspective (2002), ISBN 3-211-83791-4

        • Vol. 5: M. Faure (ed.), Deterrence, Insurability and Compensation in Environmental Liability. Future Developments in the European Union (2003), ISBN 3-211-83863-5

        • Vol. 6: T. Schobel, Der Ersatz frustrierter Aufwendungen. Vermögens- und Nichtvermögensschaden im österreichischen und deutschen Recht (2002), ISBN 3-211-83877-5

        • Vol. 7: Jos Dute, Michael G. Faure & Helmut Koziol (eds.), Liability for and Insurability of Biomedical Research with Human Subjects in a Comparative Perspective (2004), ISBN 3-211-20098-3

        • Vol. 8: Jos Dute, Michael G. Faure & Helmut Koziol (eds.), No-Fault Compensation in the Health Care Sector (2004), ISBN 3-211-20799-6

        • Vol. 9: W. van Boom, H. Koziol & Ch. A. Witting (eds.), Pure Economic Loss (2004), ISBN 3-211-00514-5

        • Vol. 10: H. Koziol/J. Spier (eds.), Liber Amicorum Pierre Widmer (2003), ISBN 3-211-83877-5

        • Vol. 11: B.A. Koch (ed.), Terrorism, Tort Law and Insurance (2004), ISBN 3-211-01867-0

        • Vol. 12: H. Koziol/W. Doralt (eds.), Abschlussprüfer. Haftung und Versicherung (2004), ISBN 3-211-20800-3

e ÀÇ·á»ç°í¿¬±¸¼Ò ¸ÞÀÏ
º» »çÀÌÆ®ÀÇ Á¤º¸´Â ¹Ì¿Ï¼ºÀ̸ç Âü°í¿ë¿¡ ºÒ°úÇÕ´Ï´Ù.